Sometimes the market rewards companies that simply deliver what they promised—and maybe a bit more. That's the story for MillerKnoll Inc. (MLKN) on Thursday, as shares of the office furniture maker jumped roughly 9% in premarket trading after the company posted better-than-expected quarterly results and offered an encouraging outlook for the months ahead.
The company reported adjusted earnings of 43 cents per share for its second quarter, topping the analyst consensus of 41 cents. Revenue came in at $955.2 million, beating the Street estimate of $943.13 million. And crucially, management issued strong guidance for the current quarter, giving investors reason to believe the momentum isn't just a one-quarter blip.
MillerKnoll shares climbed 8.8% to $19.07 in premarket action, a solid vote of confidence from traders digesting the numbers.
But MillerKnoll wasn't flying solo in the premarket session. A diverse cast of companies saw their stocks swing wildly on everything from pipeline news to clinical trial results to regulatory scrutiny. Here's the rundown of who's moving and why.
The Big Winners
Leading the charge was Sable Offshore Corp (SOC), which rocketed 44.5% to $7.63 after federal authorities confirmed interstate pipeline classification for the company. That's the kind of regulatory win that can completely reshape a business outlook overnight.
Safe Pro Group Inc. (SPAI) surged 27% to $4.10, riding enthusiasm over its newly filed patent application for AI-powered computer vision technology. The Florida-based company says the tech is designed to detect small explosive threats in drone-based video and imagery—a niche but potentially valuable application in an increasingly drone-filled world.
urban-gro Inc. (UGRO) bounced back with a 23.3% gain to $0.37, recovering some ground after dropping around 17% on Wednesday. Sometimes stocks just need to catch their breath.
Akanda Corp (AKAN) added 16.2% to $0.86, while Linkhome Holdings Inc. (LHAI) also rose 16.2% to $10.81 after getting hammered with a 27% decline the previous day.
Vivakor inc (VIVK) jumped 14.1% to $0.058, bouncing back from a 15% drop on Wednesday. IGC Pharma Inc (IGC) gained 11.1% to $0.36, and Village Farms International Inc. (VFF) climbed 11.2% to $4.65.
Then there's Micron Technology Inc. (MU), up 9.4% to $247.20 after delivering a strong performance in its first quarter of fiscal 2026. The memory chip giant beat earnings expectations and issued robust guidance for the second quarter, reminding investors that the AI-driven demand for semiconductor components remains very real.
The Big Losers
Not everyone got to celebrate Thursday morning. Mega Fortune Co Ltd (MGRT) plunged 53.5% to $6.07, giving back much of Wednesday's massive 144% surge. What goes up fast can come down even faster, especially in volatile small-cap territory.
Actelis Networks Inc. (ASNS) tumbled 49.1% to $0.56 after announcing the pricing of a $5 million public offering. Dilution fears tend to hit hard and fast when new shares are coming to market.
Ryvyl Inc. (RVYL) dropped 36.2% to $0.17 following stockholder approval of annual meeting proposals. Sometimes corporate housekeeping triggers unexpected market reactions, even when the outcome was expected.
Origin Materials Inc (ORGN) fell 34.7% to $0.22, extending its slide after already declining around 8% on Wednesday. The selling pressure just kept building.
Vision Marine Technologies Inc. (VMAR) sank 33.8% to $0.33 after announcing the pricing of a public offering, another case where the prospect of dilution sent existing shareholders heading for the exits.
Processa Pharmaceuticals Inc. (PCSA) declined 26.8% to $4.89, cooling off after a spectacular 122% jump on Wednesday. The initial rally came after the company reported preliminary Phase 2 data showing PCS6422 plus capecitabine increased cancer-killing metabolite exposure while maintaining comparable safety to capecitabine monotherapy. But profit-taking appears to have set in quickly.
Insmed Inc. (INSM) took a serious hit, dropping 20.1% to $158.59 after halting its Brensocatib CRSsNP program. The Phase 2b trial missed both primary and secondary endpoints, a double disappointment that leaves the company scrambling to adjust its development strategy.
AlphaTON Capital Corp (ATON) slid 15% to $0.78 after issuing a clarification and cancelling its Anduril Industries tokenized investment program due to transfer restrictions. When a marquee initiative gets scrapped, the market tends to ask uncomfortable questions about what's next.
DBV Technologies SA – ADR (DBVT) dipped 12.6% to $19.72, pulling back after a 25% surge on Wednesday when the company announced topline results from the Phase 3 VITESSE trial met its primary endpoint. Strong trial results are great, but apparently investors decided the initial reaction was a bit too enthusiastic.
And finally, Instacart (CART) fell 6.6% to $42.62 on news that the U.S. Federal Trade Commission is investigating the company's AI pricing tool. Regulatory scrutiny is never fun, especially when it involves pricing practices that directly affect consumers.
The premarket session offered a little bit of everything—earnings beats, regulatory wins, clinical trial setbacks, and the ever-present specter of dilution from public offerings. Some stocks are celebrating, others are licking their wounds, and all of them are reminding us that before the opening bell rings, anything can happen.
